CMS pushed to set national policy on Aduhelm access
(By Nick Moran for Becker’s Hospital Review) The Alzheimer’s Association joins insurers as the latest to call for CMS to
Read More
Part D/Prescription Drugs
When and how will we know if we need Covid-19 booster shots?
(By the STAT Staff) There’s a lot we don’t yet know about the data behind Pfizer and BioNTech’s renewed push
Read MoreWhy the pharmaceutical industry has ‘mixed views’ on Biden’s latest executive order
(By Katie Adams for Becker’s Hospital Review) The American Pharmacists Association “has mixed views” on the executive order President Joe
Read MoreWhy We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
(By Elisabeth Rosenthal for Kaiser Health News) The Food and Drug Administration’s approval in June of a drug purporting to
Read MoreDrugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
(By Michael McAuliff for Kaiser Health News) The largest drug companies are far more interested in enriching themselves and investors
Read MoreHow to pick a Medigap plan that’s right for you
If you have about to turn age 65, you are receiving confusing literature on your Medicare choices. One choice you
Read MoreDelta Is Now The Dominant Coronavirus Variant In The U.S.
(By Jane Greenhalgh and Rob Stein for NPR) The highly contagious delta variant now accounts for more than 51% of
Read MoreJuly price hikes have been announced for 32 brand drugs
According to GoodRx, price hikes by pharmaceutical manufacturers are averaging 3.6 percent for the month of July. with the recent
Read MorePaying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
(By Judith Graham for Kaiser Health News) If you could invest $56 billion each year in improving health care for
Read MoreHow One Rural Town Without a Pharmacy Is Crowdsourcing to Get Meds
(By Markian Hawryluk for Kaiser Health News) WALDEN, Colo. — The building that once housed the last drugstore in this
Read More